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Understanding the impacts of histone modification 
could aid in disease diagnosis and treatment 
Furthermore, overexpression of enhancer of zeste homo-
log 2, a catalytic subunit involved in the methylation of His-
tone 3 Lysine 27, promoted atherosclerosis in mice [3].
However, while some modification are associated with 
specific gene regions, the role of individual modifications 
in driving gene regulation is unknown.
The C. elegans histones and their modifiers, which have clear 
human orthologs, play a role in overall cell differentiation and 
gene regulation [4].
dCas9-mediated histone methylation 
can be used to induce specific histone modifications
Inactivated Cas9(dCas9) [5] can be used to guide histone modifying enzymes (HME) to target regions [6].
In mice, SMYD2, a methyltransferase of Lysine 36 on 
Histone 3, was implicated as a mediator of renal cyst 
growth [2]. 
Histones are mediators of gene expression that can 
change DNA availability to transcriptional machinery.
These observations suggest that mutations in a 
histone modifier and histone modifications can 
influence gene expression and therefore disease 
progression.
Experimental design for expressing dCas9 or 
dCas9-H3K36-methyltransferase in C. elegans
-Confirm expression of the dCas9 transgene
-Quantify effects of dCas9 fusion products on gene expression
-Determine the specificity of the binding of dCas9 using chromatin immunoprecipitation as described below.
dCas9 binding may modestly increase variability in 
gene expression
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The dCas9 transgene was created from a template plasmid (pDD122) [7] by Gibson Assembly. Overlapping primers 
were used to mutate Cas9 to dCas9, and to transfer the sequence to a homology repair template (HRT). The HRT 
was inserted into C. elegans using Mos1-mediated Single Copy gene Insertion (MosSCI) [8]. A transgene with mes-4, 
a H3K36 methyltransferase, was also created and inserted using the same methods.  
Pubiq::gfp II; dCas9 gfp-sgRNA III
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Psoma::gfp dCas9 gfp-sgRNA III
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To evaluate the effects of dCas9 binding on gene expression, dCas9 guided by gfp-sgRNA was mated with 
worms containing gfp transgenes.  
dCas9 binding to a ubiqutously expressing gfp (gtbp-1::gfp) and a somatic gfp (Pdpy-30::gfp) did not 
signficantly influence fluorescence intensity (n≥ 30). Red outline denotes area where fluorescence was 
quantified.
dCas9 binding to a ubiqutously expressing gfp (gtbp-1::gfp) did modestly increase(*) the variance of 
fluorescence in somatic tissue(p=0.067; n≥30), but this was not found in worms solely expressing gfp in 
somatic tissues. Red outline denotes area where fluorescence was quantified.
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Certain histone modifications are 
associated with chromatin compac-
tion, leading to transcriptional repres-
sion, while others are associated with 
unwinding the DNA from the histone 
complex, allowing for increased tran-
scriptional activity [1].
dCas9 binding may sterically hinder the progression of 
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-Quantify the effects of site specific binding
-Quantify the effects of strand-dependent binding
